跳至主要内容
临床试验/NCT01022463
NCT01022463已完成3 期

Effect of Ivabradine vs Atenolol on Heart Rate and Effort Tolerance in Patients With Mild to Moderate Mitral Stenosis and Normal Sinus Rhythm

Govind Ballabh Pant Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2009年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Change in effort tolerance ( in minutes/Mets) from baseline with the study drugs at the end of stipulated 4 weeks

研究概览

简要总结

The purpose of this study is to study the effect of Ivabradine vs Atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Mild to moderate mitral stenosis (Mitral valve area: 1.0 cm2 - 2.0 cm2 on echocardiography) with normal sinus rhythm
  • Age >18 years
  • Need for rate control therapy for symptoms

排除标准

  • Atrial fibrillation
  • Other significant valvular lesions (More than mild AS/AR/MR)
  • Denial of consent
  • Unable to do TMT/Contraindication for TMT
  • Need for surgical treatment or BMV
  • Presence of significant non-cardiac co-morbidities

研究组 & 干预措施

Ivabradine

Active Comparator

Crossover study to compare ivabradine and atenolol

干预措施: Ivabradine (Drug)

Ivabradine

Active Comparator

Crossover study to compare ivabradine and atenolol

干预措施: Atenolol (Drug)

Atenolol

Placebo Comparator

干预措施: Atenolol (Drug)

结局指标

主要结局

Change in effort tolerance ( in minutes/Mets) from baseline with the study drugs at the end of stipulated 4 weeks

时间窗: 4 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验